Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

Genome sequenced using hand-held device

Country: United Kingdom

UK researchers have reported sequencing the whole genomes of a human donor and a patient using a hand-held device based on nanopore technology. The device was developed by Oxford Nanopore Technologies Ltd, a venture capital-backed company based in Oxford UK.

Read more

Actelion, Johnson & Johnson confirm talks

Country: Switzerland

Switzerland-based Actelion Ltd and Johnson & Johnson Inc have confirmed that they are in discussions about a “potential transaction.” This is the second negotiation involving Actelion in a little over a year.

Read more

Eli Lilly Alzheimer’s drug fails

Country: United States

Read more

Two more deaths in Juno immunotherapy trial

Country: United States

Read more

Kite outlines regulatory plans

Country: United States

Read more

Novartis acquires Selexys

Country: Switzerland

Read more

Safety mechanism for autoimmunity

Country: Sweden

Read more

Gut linked to drug response

Country: United Kingdom

Read more

Transcription factor guides mitosis

Country: France

Read more

Damaged neurons repaired

Country: Germany

Read more

Cell Medica goes allogeneic

Country: United Kingdom

Read more

CureVac secures new investors

Country: Germany

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

Cheap capital gives rise to integrated pharma R&D by John Rountree

CommentaryJohnRountreeNov-Dec2016.pdf

Highlights of the November/December 2016 MedNous issue

The November/December 2016 MedNous features:

Latest Mednous cover
  • Antibiotic Review
    New approaches to antibiotic development
  • Oncology Development
    Many first-in-class compounds reach late-stage development
    By Bruno Pagliara
  • Commentary
    Cheap capital gives rise to integrated R&D
    By John Rountree
  • Regenerative Medicine
    Regulators discuss cell-based cancer immunotherapies
  • Commentary
    Thought disruption in R&D discovery
    By Tony Sedgwick
  • Clinical Research
    Setbacks for Lilly and Juno

The latest MedNous journal. Subscribe to download.

Recent Appointments

Neil Miller named CEO at Auspherix
Jörg Vollmer becomes CSO at Rigontec
Irina Antonijevic becomes CMO at vasopharm
Christophe Bonny joins Enterome